Morphic to participate in jefferies global healthcare conference

Waltham, mass., may 31, 2024 (globe newswire) -- morphic therapeutic (nasdaq: morf), a biotechnology company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced that members of its management team will take part in a fireside chat at the 2024 jefferies global healthcare conference on wednesday, june 5th, at 10:30 am et.
MORF Ratings Summary
MORF Quant Ranking